No Data
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
Express News | HC Wainwright & Co. Reiterates Buy on Adverum Biotechnologies, Maintains $30 Price Target
Express News | Adverum Biotechnologies Q1 2024 Adj EPS $(1.50) Misses $(1.40) Estimate
Express News | Adverum Biotechnologies Inc: $193.3 Mln in Cash, Cash Equivalents and Short-Term Investments Expected to Fund Operations Into Late 2025
Adverum Biotechnologies | 10-Q: Quarterly report
Adverum Biotechnologies 1Q Loss/Shr $1.50 >ADVM
Adverum Biotechnologies 1Q Loss/Shr $1.50 >ADVM